ENBIOCO., LTD. · 임원ㆍ주요주주특정증권등소유상황보고서
Report on Specified Securities Owned by Officers and Major Shareholders
6.1
인바이오 주식회사
20261023
Report on Specified Securities Owned by Officers and Major Shareholders
| To: Securities and Futures Commission | ||
| To: Korea Exchange | ||
| Reporting obligation date: | 2026-11-03 | |
| Report reference date: | 2026-11-10 | |
| ※ The reporting person confirms that ownership of specified securities as of the reference date is accurately stated per applicable laws and filing instructions, with no material misstatement or omission. |
| Reporting person: | 이 혁 재 |
| Company Name | 인바이오 주식회사 | ||
| Entity type | KOSDAQ-Listed Company | Company code | 352940 |
| Total Shares Issued | 10,867,730 | ||
| Report Type | Change | Reporting person type | Individual (Domestic) | |
| Name (Entity Name) | Korean | 이혁재 | Chinese characters (English) | 李赫宰(LEE HYUK JAE) |
| Date of Birth or Business Registration No., etc. | 680428 | |||
| Address (Head Office) [Town/District Level Only] | 경기도 용인시 수지구 성복동 | |||
| Relationship to Issuer | Officer (Registered or Not) | Registered Officer | Position | CEO |
| Appointment Date | 2019-08-01 | Resignation Date | - | |
| Major Shareholder | - | |||
| Business contact and person in charge | Affiliated company | 인바이오 주식회사 | Department | 경영관리본부 |
| Position | Manager | Phone Number | 031-47** | |
| Name | 주혜원 | Fax number | 031-47** | |
| Email address | **@enbiomix.co.kr | |||
| Report reference date | Specified Securities | Share Certificates | |||
| Number of Specified Securities (shares) | Ratio (%) | Number of Shares (shares) | Ratio (%) | ||
| Previous Report | 2026-10-22 | 100,399 | 0.92 | 100,399 | 0.92 |
| This Report | 2026-11-10 | 103,083 | 0.95 | 103,083 | 0.95 |
| Change | 2,684 | 0.03 | 2,684 | 0.03 | |
| Details of Specified Securities | |||||||||
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Participating Bonds | Exchangeable bonds | Depositary receipts | Other | Total | |
| Number of shares | Ratio (%) | ||||||||
| 103,083 | - | - | - | - | - | - | - | 103,083 | 0.95 |
| A | B | C | D | E | F | G | H | ||
| I | |||||||||
| Total Shares Issued (J) | Number of Specified Securities Other Than Shares (B+C+D+E+F+G+H=I) | Ownership ratio (%) | |
| Ownership Ratio of Specified Securities [A+I / J+I-(F+G+H)※] × 100 | Shareholding Ratio (A / J) × 100 | ||
| 10,867,730 | - | 0.95 | 0.95 |
※ Ownership ratio excludes from the denominator only exchangeable bonds exchangeable into shares and depositary receipts, derivative-linked securities, etc. with shares as underlying
| Reason for Report | Change Date* | Type of Specified Securities | Shares Owned (shares) | Acquisition/Disposal Unit Price (KRW)** | Remarks | Trading plan report date | ||
| Before Change | Change | After Change | ||||||
| On-Market Purchase (+) | 2026-10-23 | Common Stock | 100,399 | 14 | 100,413 | 1,941 | - | - |
| On-Market Purchase (+) | 2026-10-27 | Common Stock | 100,413 | 92 | 100,505 | 1,927 | - | - |
| On-Market Purchase (+) | 2026-10-28 | Common Stock | 100,505 | 142 | 100,647 | 1,934 | - | - |
| On-Market Purchase (+) | 2026-10-30 | Common Stock | 100,647 | 603 | 101,250 | 1,924 | - | - |
| On-Market Purchase (+) | 2026-11-03 | Common Stock | 101,250 | 387 | 101,637 | 1,907 | - | - |
| On-Market Purchase (+) | 2026-11-04 | Common Stock | 101,637 | 169 | 101,806 | 1,957 | - | - |
| On-Market Purchase (+) | 2026-11-05 | Common Stock | 101,806 | 68 | 101,874 | 1,970 | - | - |
| On-Market Purchase (+) | 2026-11-06 | Common Stock | 101,874 | 151 | 102,025 | 1,924 | - | - |
| On-Market Purchase (+) | 2026-11-09 | Common Stock | 102,025 | 264 | 102,289 | 1,920 | - | - |
| On-Market Purchase (+) | 2026-11-10 | Common Stock | 102,289 | 794 | 103,083 | 1,912 | - | - |
| Total | 100,399 | 2,684 | 103,083 | - | - | |||
* For trades on the securities market, the settlement date
** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities